14.10.2019 MediClin AG  DE0006595101

DGAP-News: Change in the Supervisory Board of MEDICLIN


 

DGAP-News: MediClin AG / Key word(s): Personnel
Change in the Supervisory Board of MEDICLIN

14.10.2019 / 14:47
The issuer is solely responsible for the content of this announcement.


Offenburg, 14 Oktober, 2019

Change in the Supervisory Board of MEDICLIN

Today, the Chairmann of the Supervisory Board of MEDICLIN Aktiengesellschaft (MEDICLIN), Dr. Ulrich Wandschneider, informed the Management Board and the Supervisory Board that he resigns from his mandate as a member of the Supervisory Board and thus also his chairmanship for personal reasons as of 15 November 2019, taking into account the notice period agreed in the Articles of Association.

Dr. Ulrich Wandschneider was Chairman of the Management Board of MEDICLIN from November 2004 until end of May 2012. Since June 2012, he is a member of the Supervisory Board of the company and chairman of this body.

The Management Board Members of MEDICLIN regret the decision of
Dr. Ulrich Wandschneider and they thank him for the trusting and constructive cooperation.

 

About MEDICLIN AG (Ticker: MED; WKN: 659 510)

MEDICLIN owns 36 clinics, seven nursing care facilities, two in-home elder care services and ten medical care centres. The Group has about 8,350 beds and a headcount of more than 10,000. With its strong network, MEDICLIN can offer its patients integrated care from the first visit to the doctor to surgery, post-operative rehabilitation and follow-up care at home. Doc-tors, therapists and nurses work together closely to achieve the best results. MEDICLIN plans the care of persons in need in accordance with their individual requirements and personal needs, either at home or in a nursing care facility.

MEDICLIN - A company of the Asklepios Group.



14.10.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: MediClin AG
Okenstraße 27
77652 Offenburg
Germany
Phone: +49 (0)781 488-326
Fax: +49 (0)781 488-184
E-mail: [email protected]
Internet: www.mediclin.de
ISIN: DE0006595101
WKN: 659510
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 889799

 
End of News DGAP News Service

889799  14.10.2019 

fncls.ssp?fn=show_t_gif&application_id=889799&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 609,08 645,11 673,09 659,86 673,14 704,70 730,07
EBITDA1,2 27,01 37,35 93,58 77,50 85,22 90,92 98,73
EBITDA-Marge3 4,43 5,79 13,90 11,74 12,66 12,90
EBIT1,4 6,62 15,06 22,41 0,15 11,56 19,52 12,72
EBIT-Marge5 1,09 2,33 3,33 0,02 1,72 2,77 1,74
Jahresüberschuss1 3,96 7,76 9,68 -0,04 1,49 9,72 -10,72
Netto-Marge6 0,65 1,20 1,44 -0,01 0,22 1,38 -1,47
Cashflow1,7 19,34 29,77 69,59 118,69 81,97 34,64 78,00
Ergebnis je Aktie8 0,08 0,16 0,20 -0,19 0,03 0,20 -0,23
Dividende8 0,05 0,05 0,05 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: PricewaterhouseCoopers

INVESTOR-INFORMATIONEN
©boersengefluester.de
Mediclin
WKN Kurs in € Einschätzung Börsenwert in Mio. €
659510 2,840 Halten 134,90
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
10,92 19,30 0,56 21,35
KBV KCV KUV EV/EBITDA
0,69 1,73 0,18 1,57
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,00 0,00 0,00 06.06.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
02.05.2024 31.07.2024 04.11.2024 26.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
10,21% 4,30% 3,65% -7,79%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu MediClin AG  ISIN: DE0006595101 können Sie bei EQS abrufen


Pflegeeinrichtungen , 659510 , MED , XETR:MED